NDC 43742-2021 – DysBio Plus
Echinacea Angustifolia Whole 3 [hp_X]/mL; Aloe 7 [hp_X]/mL; Colchicum Autumnale Bulb 8 [hp_X]/mL; Citrullus Colocynthis Fruit Pulp 8 [hp_X]/mL; Mercuric… · Liquid · Oral
Product NDC43742-2021
Product details
- Brand name
- DysBio Plus
- Generic name
- Echinacea (Angustifolia), Aloe, Colchicum Autumnale, Colocynthis, Mercurius Corrosivus, Nux Vomica, Arsenicum Album, Aceticum Acidum, Chininum Sulphuricum, Cholera Nosode, Proteus (Vulgaris), Colibacillinum Cum Natrum Muriaticum, Helicobacter Pylori, Botulinum, Salmonella Typhi Nosode, Morgan Gaertner, Clostridium Difficile, Brugia Malayi
- Labeler
- Deseret Biologicals, Inc.
- Dosage form
- Liquid
- Route
- Oral
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketed since
- June 28, 2021
- Marketing end
- September 26, 2027
- Pharmacologic class
- Acetylcholine Release Inhibitor; Antimalarial; Neuromuscular Blocker; Non-Standardized Plant Allergenic Extract
Active ingredients
- Echinacea Angustifolia Whole 3 [hp_X]/mL
- Aloe 7 [hp_X]/mL
- Colchicum Autumnale Bulb 8 [hp_X]/mL
- Citrullus Colocynthis Fruit Pulp 8 [hp_X]/mL
- Mercuric Chloride 8 [hp_X]/mL
- Strychnos Nux-vomica Seed 8 [hp_X]/mL
- Arsenic Trioxide 8 [hp_X]/mL
- Acetic Acid 12 [hp_X]/mL
- Quinine Sulfate 12 [hp_X]/mL
- Vibrio Cholerae 12 [hp_X]/mL
- Proteus Vulgaris 16 [hp_X]/mL
- Escherichia Coli 30 [hp_X]/mL
- Helicobacter Pylori 30 [hp_X]/mL
- Botulinum Toxin Type A 30 [hp_X]/mL
- Salmonella Enterica Subsp. Enterica Serovar Typhi 33 [hp_X]/mL
- Salmonella Enterica Enterica Serovar Enteritidis 30 [hp_C]/mL
- Clostridium Difficile 30 [hp_C]/mL
- Brugia Malayi 39 [hp_C]/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 43742-2021-1 | 30 mL in 1 BOTTLE, DROPPER (43742-2021-1) | Jun 28, 2021 |
Other Dysbio Plus products
- 43742-2084 Echinacea Angustifolia Whole 3 [hp_X]/mL; Aloe 7 [hp_X]/mL; Colchicum… · Liquid · Deseret Biologicals, Inc.
- 43742-2120 Acetic Acid 12 [hp_X]/mL; Aloe 7 [hp_X]/mL; Arsenic Trioxide 8… · Liquid · Deseret Biologicals, Inc.